Summary Miraculins Inc. (Miraculins) is a biotechnology company that offers therapeutic products. The company acquires, develops and commercializes risk assessment tests, and non invasive diagnostic tests for the healthcare market. It provides discovery and validation of cancer biomarkers for development of diagnostic tools and therapeutic products. Miraculins's products include prevu non-invasive skin cholesterol test and scout DS non-invasive diabetes screening test. The company's testing services utilizes PSP94 RUO kit and the B.E.S.T platform technology for screening and identification of target proteins and peptides related to diseases. It offers medical devices and consumables to clinics and physician's offices, and hospitals; provides retail testing through pharmacies and grocery chains. Miraculins is headquartered in Winnipeg, Manitoba, Canada. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Miraculins Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Miraculins Inc. Company Snapshot 6 Miraculins Inc. Company Overview 6 Miraculins Inc. Pipeline Products and Clinical Trials Overview 7 Miraculins Inc. - Pipeline Analysis Overview 9 Key Facts 9 Miraculins Inc. - Major Products and Services 10 Miraculins Inc. Pipeline Products by Development Stage 11 Miraculins Inc. Clinical Trials by Trial Status 13 Miraculins Inc. Pipeline Products Overview 14 Diagnostic Test - Colorectal Cancer 14 Diagnostic Test - Colorectal Cancer Product Overview 14 Diagnostic Test - Gastric Cancer 15 Diagnostic Test - Gastric Cancer Product Overview 15 Diagnostic Test - Pancreatic Cancer 16 Diagnostic Test - Pancreatic Cancer Product Overview 16 Diagnostic Test - Preeclampsia 17 Diagnostic Test - Preeclampsia Product Overview 17 Next Geneation PreVu LP Test 18 Next Geneation PreVu LP Test Product Overview 18 Prostate Cancer Diagnostic Test 19 Prostate Cancer Diagnostic Test Product Overview 19 Scout DS System 20 Scout DS System Product Overview 20 Scout DS System Clinical Trial 21 Miraculins Inc. - Key Competitors 22 Miraculins Inc. - Key Employees 23 Miraculins Inc. - Locations And Subsidiaries 24 Head Office 24 Recent Developments 25 Miraculins Inc., Recent Developments 25 Nov 11, 2015: Miraculins Announces Strategic Review Process 25 Aug 13, 2015: Miraculins Makes Supplemental Filing With U.S. FDA Related to De Novo Marketing Clearance Pathway of Its Scout Device 25 Jul 06, 2015: Scout Research Receives Attention at Recent American Diabetes Association Scientific Sessions 25 Jun 04, 2015: Promising Results from Miraculins and Amway Scout DS Study Accepted for the 23rd World Congress of Dermatology 26 May 22, 2015: Miraculins Updates Market on Regulatory Progress in China for its Scout DS Diabetes Screening Device 26 Apr 28, 2015: Miraculins Receives Guidance from U.S. FDA Related to Its Scout Device as an Aid in the Identification of Pre-Diabetes 27 Mar 10, 2015: Miraculins Appoints Leading Occupational Health Physician to the Scout DS Medical Advisory Board 28 Mar 05, 2015: Miraculins Reports on Positive Results as the First Pharmacy Pilot for the Scout DS Diabetes Screening Kiosk Nears Completion 28 Feb 18, 2015: Miraculins Provides Pre-Submission De Novo Documentation to FDA for its Scout Diabetes Technology 30 Jan 27, 2015: Miraculins Announces Retail Pharmacy Pilot for its Scout DS Diabetes Screen 30 Appendix 32 Methodology 32 About GlobalData 32 Contact Us 32 Disclaimer 32
List of Tables
Miraculins Inc. Pipeline Products and Clinical Trials Overview 7 Miraculins Inc. Pipeline Products by Equipment Type 7 Miraculins Inc. Pipeline Products by Indication 8 Miraculins Inc. Clinical Trials by Trial Status 8 Miraculins Inc., Key Facts 9 Miraculins Inc., Major Products and Services 10 Miraculins Inc. Number of Pipeline Products by Development Stage 11 Miraculins Inc. Pipeline Products Summary by Development Stage 12 Miraculins Inc. Clinical Trials by Trial Status 13 Miraculins Inc. Clinical Trials Summary 13 Diagnostic Test - Colorectal Cancer - Product Status 14 Diagnostic Test - Colorectal Cancer - Product Description 14 Diagnostic Test - Gastric Cancer - Product Status 15 Diagnostic Test - Gastric Cancer - Product Description 15 Diagnostic Test - Pancreatic Cancer - Product Status 16 Diagnostic Test - Pancreatic Cancer - Product Description 16 Diagnostic Test - Preeclampsia - Product Status 17 Diagnostic Test - Preeclampsia - Product Description 17 Next Geneation PreVu LP Test - Product Status 18 Next Geneation PreVu LP Test - Product Description 18 Prostate Cancer Diagnostic Test - Product Status 19 Prostate Cancer Diagnostic Test - Product Description 19 Scout DS System - Product Status 20 Scout DS System - Product Description 20 Scout DS System - First Pharmacy Pilot for the Scout DS Diabetes Screening Kiosk 21 Miraculins Inc., Key Employees 23
List of Figures
Miraculins Inc. Pipeline Products by Equipment Type 8 Miraculins Inc. Pipeline Products by Development Stage 11 Miraculins Inc. Clinical Trials by Trial Status 13
Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likelyRead More...
Global embedded system market is projected to be valued at USD 214.39 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising demand from end-use industries such as automotive and healthcare coupled with emergence of Internet oRead More...
U.S hairbrush market is estimated to exceed USD 1.2 billion by 2022, as per a new research report by Radiant Insights, Inc. Rising population along with ascending disposable income is expected to drive industry demand. Significant rise in disposableRead More...
Global aerosol propellants market is anticipated to reach USD 24.8 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing popularity of personal care and cosmetics products such as hair sprays, deodorants and shaving creamRead More...
Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demandRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.